# A Study on the Efficacy of GD2-CAR T Cells in the Treatment of Neuroblastoma

> **NCT06684639** · EARLY_PHASE1 · RECRUITING · sponsor: **The General Hospital of Western Theater Command** · enrollment: 30 (estimated)

## Conditions studied

- Neuroblastoma

## Interventions

- **BIOLOGICAL:** GD2-CAR-T cell

## Key facts

- **NCT ID:** NCT06684639
- **Lead sponsor:** The General Hospital of Western Theater Command
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2029-12-01
- **Final completion:** 2030-12-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-12-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06684639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06684639, "A Study on the Efficacy of GD2-CAR T Cells in the Treatment of Neuroblastoma". Retrieved via AI Analytics 2026-09-16 from https://api.ai-analytics.org/clinical/NCT06684639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*